Between 2017 and 2018, obesity affected about 14.4 million children and adolescents in the United States. In order to create treatments, interventions, and health policies to adequately address this issue, we need solid data from well-conducted studies. In today’s episode we discuss why we’re largely lacking such data, and how we can fix that.
Other Healthcare Triage Links: 1. Support the channel on Patreon: http://vid.io/xqXr 2. Check out our Facebook page: http://goo.gl/LnOq5z 3. We still have merchandise available at http://www.hctmerch.com 4. Aaron's book "The Bad Food Bible: How and Why to Eat Sinfully" is available wherever books are sold, such as Amazon: http://amzn.to/2hGvhKw Credits: Aaron Carroll -- Writer Meredith Danko – Social Media Tiffany Doherty -- Writer and Script Editor John Green -- Executive Producer Stan Muller -- Director, Producer Mark Olsen – Art Director, Producer
Many solutions have been proposed to address the growing problem of childhood obesity in America,
but we're not getting very far. This may be due in part to problems with the way obesity
research is being conducted. That's the topic of this week's Healthcare Treatment.
Childhood obesity is a major public health problem and has been for some time.
Almost 20% of American children are affected by obesity, as well as about 40% of adults.
Overall, this costs the United States around $150 billion in healthcare spending every year.
Pediatricians like me and many other health professionals know it's a problem,
and yet we've been relatively unsuccessful in tackling it. About seven years ago,
some reports seemed to show that rates had stabilized in children and even decreased in
those aged two to five. Later studies showed this trend to be an illusion. If anything,
things have gotten worse. Efforts to help can backfire. People on diets often gain weight.
Although individual studies have pointed to potential interventions and solutions,
these have not yet translated into actual improvements. Part of the problem may be
flawed research. A 2019 paper in Pediatric Obesity provided a guide on how to do better.
Its suggestions fall into five general themes. One. When things look better,
it's critical to ask, compared to what? In short, you need a control group. Over time,
changes in behaviors or measurements often follow a pattern known as regression towards the mean.
Outliers, in this case those who are more overweight, tend to move towards the average.
Thus, interventions might look as if they're working when they're not.
Control groups, participants who don't receive the intervention, can help ensure
that what we're seeing is real effectiveness. Even then, things can get tricky. In a randomized
controlled trial, it's important to keep the comparisons directly between the intervention
and control groups. A common mistake is comparing each group after the intervention with the same
group before the intervention. In other words, people would compare a dieting group to itself
before and after, and compare the control group to itself before and after, to see if the dieting
group achieved a significant decrease. This is known as a differences in nominal significance
error. Doing this can make an intervention look as if it achieved a significant change against
a baseline measurement, when it probably did not against the control group. Creating and studying
large obesity interventions is hard and expensive. It's only natural that researchers want them to
work. But if your well-designed study doesn't result in significant improvements in an intervention
group over a control group, you can't then fall back on claims that those who received the
intervention still lost weight. Control groups are there for a reason. You can't dismiss them after
the fact. Two, don't change the analysis plan. Before a study begins, its expected primary outcome
should be clearly defined. For most obesity studies, that's going to be a decrease in body
mass index. You can't later add in other outcomes that might show results, even if the main outcome
does not. Sometimes, to get statistically significant results, researchers will adjust
analyses in ways that achieve them. This is called p-hacking. We've talked about it before.
Changing outcomes can result in different numbers of patients qualifying through inclusion and
exclusion criteria in such a way as to change the actual groups being studied. Three, be careful
when designing studies and picking outcomes. Too often, when trying to prove that subjects changed
their diet or exercise habits, we simply ask them if they did. This risks getting results influenced
by self-report bias. If a study's focus is an educational intervention that tells students they
should walk more and watch less TV, we shouldn't be surprised that they say they did, even when
there's no change in body fat percentage. Because interventions tend to be delivered in groups,
randomly assigning by classes or schools, it's important that we analyze results only by groups.
There are only as many participants as there are groups. Too often, researchers conduct statistics
on the individuals, and when they see improvements, it's because of the differences between groups,
not the interventions. Four, not significant is not significant. Negative results, those that do
not back up the hypothesis of the researcher, should not be spun as positive. Researchers are
often tempted to argue that these results are clinically significant or that they have promise.
Sometimes, researchers want to test one intervention against an already proven one.
If they find that there's no difference, they conclude that the two are equally effective, and
that too can be a mistake. Five, don't assume that an intervention is better than nothing.
Most studies conduct a two-sided analysis. That means they look at whether an intervention is
better or worse, then consider the results significant if the p-value is less than 0.05.
In some studies, though, researchers assume that interventions can only help people lose weight,
not gain it. They therefore conduct a one-sided test, which effectively doubles the allowable p-value.
Results that would not have been significant become so. Some of these rules are technical.
Others involve not overreaching on the results, and some acknowledge that researchers are human
beings who are predisposed to want to get positive results. These are certainly true
with respect to obesity, but they're true for almost all health research. To be effective,
interventions and policies need to be built upon solid data. There are no assurances that
interventions can only do good. It's possible that interventions, almost all of which are done
on a small scale, may not be the solution. Michelle Obama's Let's Move initiative,
which was done on a large scale, was often credited in helping to slow or reverse childhood
obesity, but there's no evidence that's true. Processed food, and the advertising and marketing
of it, is one driver of the problem. So is a lack of effort and resources put towards maintaining
a healthy lifestyle. If there are no sidewalks, you may be literally unable to walk to the store
to school, for example. Major problems like poverty can't be overcome with a couple of
workshops in a school or a doctor's visit. Obesity is a major societal problem that probably requires
a major societal response. We can't allow our desire to make things better lead us to accept
lower quality research that might convince us otherwise. Hey, if you enjoyed this episode,
you might enjoy this previous episode on acetaminophen, autism, and ADHD. We'd appreciate it
if you'd like this video and subscribe to the channel down below, and consider going to
patreon.com slash healthcare triage, where you too can help support the show even during a global
pandemic. We'd like to especially thank our research associates, James Glasgow and Joe
and of course, our surgeon, Admiral Sam.